Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Ignjatovic

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|July 16, 2010
Clinical use of unfractionated heparin therapy in children: time for change?Fiona Newall, Vera Ignjatovic, Linda Johnston, et al.
Pediatric Cardiology|August 3, 2011
The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgeryVera Ignjatovic, Jenny Than, Robyn Summerhayes, et al.
The Journal of Pediatrics|June 3, 2020
Plasma Proteomic Analysis Reveals Age-Specific Changes in Platelet- and Endothelial Cell-Derived Proteins and Regulators of Plasma Coagulation and FibrinolysisConor McCafferty, Xavier Busuttil-Crellin, Tengyi Cai, et al.
Thrombosis Research|October 3, 2008
In vivo age dependency of unfractionated heparin in infants and childrenFiona Newall, Vera Ignjatovic, Robyn Summerhayes, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
"Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies, among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world data": replyAmy L Kiskaddon, Ernest K Amankwah, Daniel M Witt, et al.
Pediatric Nephrology (Berlin, Germany)|May 25, 2020
Reference intervals for serum cystatin C in neonates and children 30 days to 18 years oldTengyi Cai, Vasiliki Karlaftis, Stephen Hearps, et al.
Journal of Proteomics|February 7, 2024
Technical report: The clinically useful selection of proteins protocol: An approach to identify clinically useful proteins for validationElla E K Swaney, Stephen Hearps, Paul Monagle, et al.
Pediatric Research|February 8, 2005
Reduced bone density in children on long-term warfarinChris Barnes, Fiona Newall, Vera Ignjatovic, et al.
Thrombosis and Haemostasis|February 23, 2010
Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparinFiona Newall, Vera Ignjatovic, Linda Johnston, et al.
Proteomics|August 24, 2017
Improving Protein Detection Confidence Using SWATH-Mass Spectrometry with Large Peptide Reference LibrariesJemma X Wu, Dana Pascovici, Vera Ignjatovic, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|July 16, 2010
Clinical use of unfractionated heparin therapy in children: time for change?Fiona Newall, Vera Ignjatovic, Linda Johnston, et al.
Pediatric Cardiology|August 3, 2011
The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgeryVera Ignjatovic, Jenny Than, Robyn Summerhayes, et al.
The Journal of Pediatrics|June 3, 2020
Plasma Proteomic Analysis Reveals Age-Specific Changes in Platelet- and Endothelial Cell-Derived Proteins and Regulators of Plasma Coagulation and FibrinolysisConor McCafferty, Xavier Busuttil-Crellin, Tengyi Cai, et al.
Thrombosis Research|October 3, 2008
In vivo age dependency of unfractionated heparin in infants and childrenFiona Newall, Vera Ignjatovic, Robyn Summerhayes, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
"Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies, among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world data": replyAmy L Kiskaddon, Ernest K Amankwah, Daniel M Witt, et al.
Pediatric Nephrology (Berlin, Germany)|May 25, 2020
Reference intervals for serum cystatin C in neonates and children 30 days to 18 years oldTengyi Cai, Vasiliki Karlaftis, Stephen Hearps, et al.
Journal of Proteomics|February 7, 2024
Technical report: The clinically useful selection of proteins protocol: An approach to identify clinically useful proteins for validationElla E K Swaney, Stephen Hearps, Paul Monagle, et al.
Pediatric Research|February 8, 2005
Reduced bone density in children on long-term warfarinChris Barnes, Fiona Newall, Vera Ignjatovic, et al.
Thrombosis and Haemostasis|February 23, 2010
Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparinFiona Newall, Vera Ignjatovic, Linda Johnston, et al.
Proteomics|August 24, 2017
Improving Protein Detection Confidence Using SWATH-Mass Spectrometry with Large Peptide Reference LibrariesJemma X Wu, Dana Pascovici, Vera Ignjatovic, et al.
Pageof 19